Advanced search
Start date

Manufacturing and biological evaluations of stimuli-responsive polymersomes towards enhanced efficacy of cancer therapies


The most recent survey by the International Agency for Research on Cancer reported that the global death related to the malignancy was about 9.6 million in 2018 (21% higher than that in 2008). This number is predicted to be as high as 19.3 million by 2025 calling for improvements in cancer treatments. In the last decades, cancer therapy has also been tackled to design carriers that can navigate the body and deliver their cargos in desired site. The most successful up-to-date carrier is the pegylated liposomal formulation of doxorubicin (DOX) Doxil/Caelyx which is 100nm-sized vesicles encapsulating 10,000-15,000 DOX molecules. Doxil/Caelyx becomes one of the most sale nanotechnologies in the history of the chemotherapy which expected to generate revenue of 1.39 billion USD for 2025.Despite a 60-fold increase in the fraction of recovered dose in blood, a 4-fold increase of the recovered dose in liver and spleen and a 25-fold increase of the concentration of the liposomal formulation in tumor, the Doxil/Caelyx formulation still compromise the effectivity of the treatment due to lack of specificity and DOX leakage during blood circulation resulting in several side-effects including hand-foot syndrome, mouth pain (stomatitis), low white blood cell counts, low platelet counts, anemia, nausea and vomiting. We wish to fundamentally contribute to circumvent such drawback by designing stimuli-responsive vesicles able to controlled release the drug only under response to the inherent characteristics of the tumor microenvironment. Such features may enhance the therapeutic outcomes in comparison to the conventional cancer therapies. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
DE CASTRO, CARLOS E.; PANICO, KARINE; STANGHERLIN, LUCAS M.; RIBEIRO, CAROLINE A. S.; DA SILVA, MARIA C. C.; CARNEIRO-RAMOS, MARCELA S.; DAL-BO, ALEXANDRE G.; GIACOMELLI, FERNANDO C.. The Protein Corona Conundrum: Exploring the Advantages and Drawbacks of its Presence around Amphiphilic Nanoparticles. BIOCONJUGATE CHEMISTRY, v. 31, n. 11, p. 2638-2647, . (19/06634-8, 15/24686-4)
CERNOCH, PETER; JAGER, ALESSANDRO; CERNOCHOVA, ZULFIYA; SINCARI, VLADIMIR; ALBUQUERQUE, LINDOMAR J. C.; KONEFAL, RAFAL; PAVLOVA, EWA; GIACOMELLI, FERNANDO C.; JAGER, ELIEZER. Engineering of pH-triggered nanoplatforms based on novel poly(2-methyl-2-oxazoline)-b-poly[2-(diisopropylamino)ethyl methacrylate] diblock copolymers with tunable morphologies for biomedical applications. Polymer Chemistry, v. 12, n. 19, p. 2868-2880, . (19/06634-8, 16/23844-8, 17/11261-0)
FUENTES-GARCIA, JESUS ANTONIO; ALAVARSE, ALEX CARVALHO; DE CASTRO, CARLOS EDUARDO; GIACOMELLI, FERNANDO CARLOS; IBARRA, MANUEL RICARDO; BONVENT, JEAN-JACQUES; GOYA, GERARDO FABIAN. Sonochemical route for mesoporous silica-coated magnetic nanoparticles towards pH-triggered drug delivery system. JOURNAL OF MATERIALS RESEARCH AND TECHNOLOGY-JMR&T, v. 15, p. 52-67, . (14/50983-3, 19/06634-8)

Please report errors in scientific publications list by writing to: